Tissue engineering and reconstructive plastic surgery use common denominators to fix, improve, and sustain tissues and their functions. This can be accomplished by the use of autologous tissues in the form of flaps or transplants. Autologous tissue, on the other hand, is not always usable. This is one of the reasons for the growing interest in tissue engineering among plastic surgeons, which has resulted in beneficial cross-fertilizations between the areas. Tissue engineering is an interdisciplinary field that applies engineering and biological science ideas to the development of biologic substitutes that preserve, restore, or improve tissue functions. Tissue equivalents can be created for both clinical and in vitro testing purposes. For a variety of fundamental and practical reasons, the development of in vitro screening systems based on human cells and tissues has lately accelerated. First and foremost, there are ethical considerations to keep the number of test animals to a bare minimum.
Title : Eliminating implants infections with nanomedicine: Human results
Thomas J Webster, Interstellar Therapeutics, United States
Title : Biodistribution and gene targeting in regenerative medicine
Nagy Habib, Imperial College London, United Kingdom
Title : Graphene, butterfly structures, and stem cells: A revolution in surgical implants
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, London NW1 0NH, United Kingdom
Title : Precision in cartilage repair: Breakthroughs in biofabrication process optimization
Pedro Morouco, Polytechnic of Leiria, Portugal
Title : Keratin-TMAO wound dressing promote tissue recovery in diabetic rats via activation of M2 macrophages
Marek Konop, Medical University of Warsaw, Poland
Title : Assessing geometric simplifications in vertebral modeling for reliable numerical analysis of intervertebral discs
Oleg Ardatov, Vilnius University, Lithuania